llustration of a cell undergoing division, showing two nuclei forming within a translucent cell membrane

Opinion piece: The #FDA must regulate #StemCell therapies to mitigate risks to patients and the public. In PNAS Front Matter: https://ow.ly/RRoL50Yttgt

#StemCellTherapy #HHS #Evidence-basedMedicine #AdultStemCells #EmbryonicStemCells

Thanks for sharing the incredible work of @crumplab.bsky.social #StemCell

RESEARCH PAPER: Transcriptional derepression of negative regulators of MAP kinase supports maintenance of diapause ES cells in the pluripotent state
By Zhang et al., and Alexander Tarakhovsky
➡️ https://genesdev.cshlp.org/content/40/5-6/319.full

The Rockefeller University
#embryo #stemcell

At #GfE2026, Thomas Bosch from Kiel University (CAU) challenges the host gene-centric view of biology, demonstrating in beautiful work how microbes change #development, #StemCell differentiation, and even #behaviour. Check out doi.org/10.1073/pnas... doi.org/10.1016/j.cu... doi.org/10.1101/2024...

Early encouraging UC Davis trial data on cell therapy for spina bifida - The Niche Stem cell biologist discusses a new Lancet paper describing early results on a cell therapy for spina bifida.

ICYMI from Friday --> Upbeat news as early UC Davis trial data on cell therapy for spina bifida looks very encouraging so far ipscell.com/2026/03/earl... #stemcells #stemcell

Funding Results - Stem Cell Network Learn more about SCN’s funded projects On June 16 2025, SCN was pleased to allocate $13.5M to support 36 research projects and clinical trials across the country, with 63 partner organizations committ...

(1/5) This #IWD2026, SCN celebrates the women whose leadership is advancing world-class #StemCell and #RegenMed research across Canada. 🇨🇦

From developmental research to commercialization, women are driving innovation, mentoring future leaders, and accelerating progress for patients and families. ✨

🧬 HISTORIC: Japan approved the world's first iPS cell therapies as products.
"ReHeart" — cell sheet repairing damaged hearts
"Amshepri" — dopamine neurons for Parkinson's
20 years from Yamanaka's Nobel discovery to real medicine.
#iPSCells #StemCell #RegenerativeMedicine

An Updated Guide To #HairFollicle #StemCell Markers And Changes In Their Expression With #Aging https://ow.ly/ztsG50YkYcC #Dermatology #HairResearch #CutaneousBiology #dermsky

Check out the latest step-by-step protocols in various #LifeSciences fields.

#Biochemistry #BioinformaticsandComputationalBiology #CancerBiology #CellBiology #Microbiology #MolecularBiology #Neuroscience #PlantScience #StemCell

Longeveron's Laromestrocel for Frailty: Breaking Down Cell Stem Cell Data & Problematic Nature Coverage - The Niche Biologist provides perspectives on new MSC frailty study published in Cell Stem Cell from Longeveron and provides background.

Longeveron's Laromestrocel for Frailty: journal club on @cp-cellstemcell.bsky.social pub Data & Problematic Nature news Coverage ipscell.com/2026/03/long... #stemcells #stemcell @caulfieldtim.bsky.social

Spina bifida: in-utero stem cell treatment approach shows promise New approach could lead to better health outcomes for babies compared to traditional fetal surgery

Combining #stemcell therapy with standard fetal #surgery before birth is a safe and promising approach to treat myelomeningocele, a severe form of #SpinaBifida, a new study from 🇺🇸 @ucsfsurgery.bsky.social, published in @thelancet.com, has shown.

$24M verdict against Seattle Stem Cell Center clinic in man's death - The Niche Biologist discusses $24M verdict in case of man with ALS who died after going to Seattle Stem Cell Center and background.

Historic verdict. $24M decision against unproven stem cell clinic in Seattle in man’s death ipscell.com/2026/03/24m-... #stemcells #stemcell

🧬 Why are human legs longer than arms, but chimps have the opposite?
Kyoto & Hiroshima Univ. grew the world's first ape limb precursor cells from iPS stem cells — bonobos, chimps & gibbons.
Their "Whole-Zoo iPS Project" turns zoos into genetic libraries.
#iPSCells #StemCell

Weekly reads: longevity hype vs. cool research, losing your Y, FDA maelstrom - The Niche Biologist discusses recent regenerative news including longevity hype, TX AG sues cord blood firm, losing your Y, MSCs but no MSCs, FDA chaos

Weekly regenerative reads: longevity hype vs. new cool research including on the brain & Alzheimer's, losing your Y, FDA maelstrom continues including supposed "fatwa" on Prasad per Makary ipscell.com/2026/03/week... #stemcells #stemcell

🚀 Catch up on the latest advances in #space related #stemcell #science and #regenerativemedicine at our Global Astrobiotechnology Hub event THIS MONDAY, March 2, 2-6 p.m. PT. Complimentary online tix are still available at bit.ly/4bhqpol. 🧫

Federally supported Stem Cell Network is developing world-first “curative” stem cell therapies for many diseases - Stem Cell Network By Mark Lowey February 4, 2026 This article was published in Research Money. The Ottawa-based Stem Cell Network has used most of $45 million in federal funding to support Canadian researchers who’ve d...

(1/5) SCN President & CEO, @catemurray1.bsky.social, was featured in Research Money, discussing how federally supported investment through SCN is enabling world-first #StemCell technologies and life-saving, potentially curative therapies.

🔗 stemcellnetwork.ca/news/federal...

Be prepared
for the unlimited
potential that
progress will deliver
#crispr #crispr #medical #biotech #geneticengineering #stemcell #health #Artificalintelligence #genome

Epigenetics Update - Minimizing far-extending chromatin perturbation in genome editing preserves stem cell identity bit.ly/4tVv2LD

#Epigenetics #Chromatin #GenonmeEditing #StemCell
---

Discover the breakthrough at epigenometech.com

Molecular and phenotypic blueprint of human #hematopoiesis links proliferation stress to #StemCell #aging. From Emanuele Lettera et al. @dimiccolab.bsky.social: rupress.org/jem/article/...

📘 In Hematopoiesis and #Myeloid Cells collection: rupress.org/jem/collecti...

#KSMyeloid26 #KSHemato26

Japan panel OK's 2 iPS cell therapies despite little data - The Niche Stem cell biologist discusses the potential risks & benefits as Japan panel OK's iPS cell therapies, which are likely to be approved soon.

Panel in Japan OK’s 2 iPS cell therapies for likely conditional approval despite little clinical trial data, only 7-8 people have received the regenerative procedures ipscell.com/2026/02/japa... Let's go through the risks and context #stemcells #stemcell

🚀 Catch up on the latest advances in #space related #stemcell #science and #regenerativemedicine at our Global Astrobiotechnology Hub Event on Monday, March 2, 2-6 p.m. PT. Complimentary online tix are still available at bit.ly/4bhqpol. 🧫

#STEMCELL #ALLEN_EAVES #CONNIE_EAVES
The International Society for Stem Cell Research Honors Dr. Allen Eaves and the Late Dr. Connie Eaves with the 2026 ISSCR Lifetime Achievement Award

Transcriptomic & multiplex immunostaining datasets demonstrate that #MYO5B is critical for intestinal epithelial stem & progenitor cell functions #MVID #intestine #stemcell #proliferation #differentation https://ow.ly/W9ZK50Yim7F

ISSCR | Cell Press | The Gairdner Foundation | SickKids Foundation

Allogeneic hematopoietic stem cell transplantation for the treatment of chronic active Epstein–Barr virus infection
doi.org/10.1177/0963...
#stemcell #transplantation #virus
@journals.sagepub.com

Not the first successfully cloned animal but the first cloned mammal from an adult somatic cell, the birth and survival in Scotland of #DollyTheSheep was announced on #ThisDayInHistory in 1997. Dolly was born 5 July the previous year & her life helped advance #StemCell research.

#StemCell biologists from the Macklis lab at @harvard.edu have discovered a way to grow the type of brain cells that degenerate in patients with #ALS and suffer damage in spinal cord injuries.

🔬 Abstract in eLife: https://bit.ly/4aYbn6e
📰 Press release: https://bit.ly/4aYbnDg

Frontiers | In Vitro retinal ganglion cell differentiation and enrichment under the scope: do subtypes matter? Retinal ganglion cells (RGCs) play a pivotal part transmitting visual data to the brain. Yet, damaged RGCs are unable to maintain and regrow axons and connec...

Excited to share my new review paper @ Frontiers "In Vitro Retinal Ganglion Cell Differentiation & Enrichment: Do Subtypes Matter?" We review human RGC subtypes, markers, #glaucoma vulnerabilities & the need for subtype-specific #stemcell protocols for better therapies
Link ⬇️
#science #organoids

Frontiers | In Vitro retinal ganglion cell differentiation and enrichment under the scope: do subtypes matter? Retinal ganglion cells (RGCs) play a pivotal part transmitting visual data to the brain. Yet, damaged RGCs are unable to maintain and regrow axons and connec...

Excited to share my new pub in @ Frontiers "In Vitro Retinal Ganglion Cell Differentiation & Enrichment: Do Subtypes Matter?" We review human RGC subtypes, markers, #glaucoma vulnerabilities & the need for subtype-specific #stemcell protocols for better therapies
Link ⬇️
#science #organoids

The OG vampire people don’t really talk about.

Peter Nygård built a fashion empire while hiding decades of abuse & exploitation. As well as a strong obsession with the DNA of Black Women, stem cells & staying young.

🧛‍♀️

#PeterNygard #StemCell #Unseemly #NygardCay #EpsteinFiles

Photo of a bearded man in yellow t-shirt smiling and holding up a phone that's displaying a favorable reading of his blood sugar level. This is Ed Augustin, the first recipient of an FDA-approved islet cell treatment called Lantidra, at a follow-up appointment. Photo by Jack Martin for University of Illinois Health.

I've been closely following the quest for cell therapy "cures" for type 1 diabetes ever since my son was diagnosed with the disease 25 years ago.

Here's an excellent update on research from my friend Paul Heltzel […]

[Original post on mastodon.social]